1. Home
  2. UIS vs ANTX Comparison

UIS vs ANTX Comparison

Compare UIS & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Unisys Corporation New

UIS

Unisys Corporation New

HOLD

Current Price

$3.03

Market Cap

192.4M

Sector

Technology

ML Signal

HOLD

Logo AN2 Therapeutics Inc.

ANTX

AN2 Therapeutics Inc.

HOLD

Current Price

$4.48

Market Cap

170.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UIS
ANTX
Founded
1942
2017
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
192.4M
170.6M
IPO Year
1994
2022

Fundamental Metrics

Financial Performance
Metric
UIS
ANTX
Price
$3.03
$4.48
Analyst Decision
Strong Buy
Buy
Analyst Count
4
1
Target Price
$5.67
$2.00
AVG Volume (30 Days)
708.8K
226.4K
Earning Date
05-05-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
32.56
EPS
N/A
N/A
Revenue
$1,950,100,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.60
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.97
$1.00
52 Week High
$5.27
$6.91

Technical Indicators

Market Signals
Indicator
UIS
ANTX
Relative Strength Index (RSI) 60.78 54.69
Support Level $2.61 $1.06
Resistance Level $3.10 $5.14
Average True Range (ATR) 0.20 0.41
MACD -0.00 -0.05
Stochastic Oscillator 59.26 43.50

Price Performance

Historical Comparison
UIS
ANTX

About UIS Unisys Corporation New

Unisys Corp is engaged in the provision of technology solutions for clients across the government, financial services, and commercial markets. It operates through three business segments: Digital Workplace Solutions (DWS),Cloud, Applications & Infrastructure Solutions (CA&I), and Enterprise Computing Solutions (ECS). DWS provides workplace solutions featuring intelligent workplace services, proactive experience management and collaboration tools to support business growth. CA&I which provides digital transformation in the areas of cloud migration and management. ECS which provides solutions that harness secure, high-intensity enterprise computing and enable digital services through software-defined operating environments. maximum of revenue is from CA&I segment.

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.

Share on Social Networks: